127 related articles for article (PubMed ID: 24024557)
1. Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.
Lu SH; Yuan RH; Chen YL; Hsu HC; Jeng YM
Histopathology; 2013 Nov; 63(5):640-8. PubMed ID: 24024557
[TBL] [Abstract][Full Text] [Related]
2. Podocalyxin-like protein 1 expression is useful to differentiate pancreatic ductal adenocarcinomas from adenocarcinomas of the biliary and gastrointestinal tracts.
Ney JT; Zhou H; Sipos B; Büttner R; Chen X; Klöppel G; Gütgemann I
Hum Pathol; 2007 Feb; 38(2):359-64. PubMed ID: 17137615
[TBL] [Abstract][Full Text] [Related]
3. Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary.
Isidro RA; Abukhiran I; Dunseth CD; Gosse MD; Humble RM; Pelletier DJ; Varshney N; Bellizzi AM; Hornick JL
Am J Surg Pathol; 2023 Apr; 47(4):440-452. PubMed ID: 36730833
[TBL] [Abstract][Full Text] [Related]
4. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
Kim JK; Kim PJ; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Shan JM; Ping WY; Park WS; Lee JY; Nam SW
Oncol Rep; 2010 Sep; 24(3):607-12. PubMed ID: 20664964
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma.
Kim J; Kim MA; Jee CD; Jung EJ; Kim WH
Int J Cancer; 2009 Oct; 125(8):1842-50. PubMed ID: 19582876
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Typing of Adenocarcinomas of the Pancreatobiliary System Improves Diagnosis and Prognostic Stratification.
Fernández Moro C; Fernandez-Woodbridge A; Alistair D'souza M; Zhang Q; Bozoky B; Kandaswamy SV; Catalano P; Heuchel R; Shtembari S; Del Chiaro M; Danielsson O; Björnstedt M; Löhr JM; Isaksson B; Verbeke C; Bozóky B
PLoS One; 2016; 11(11):e0166067. PubMed ID: 27829047
[TBL] [Abstract][Full Text] [Related]
7. Annexin A10 is a candidate marker associated with the progression of pancreatic precursor lesions to adenocarcinoma.
Zhu J; Wu J; Pei X; Tan Z; Shi J; Lubman DM
PLoS One; 2017; 12(4):e0175039. PubMed ID: 28369074
[TBL] [Abstract][Full Text] [Related]
8. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors.
Meriden Z; Yemelyanova AV; Vang R; Ronnett BM
Am J Surg Pathol; 2011 Feb; 35(2):276-88. PubMed ID: 21263249
[TBL] [Abstract][Full Text] [Related]
9. Claudin-18 as a Marker for Identifying the Stomach and Pancreatobiliary Tract as the Primary Sites of Metastatic Adenocarcinoma.
Li WT; Jeng YM; Yang CY
Am J Surg Pathol; 2020 Dec; 44(12):1643-1648. PubMed ID: 32925194
[TBL] [Abstract][Full Text] [Related]
10. Hepatocyte nuclear factor 4A expression discriminates gastric involvement by metastatic breast carcinomas from primary gastric adenocarcinomas.
Koyama T; Sekine S; Taniguchi H; Tsuda H; Ikegami M; Hano H; Kushima R
Hum Pathol; 2011 Nov; 42(11):1777-84. PubMed ID: 21733563
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma.
Tsai JH; Lin YL; Cheng YC; Chen CC; Lin LI; Tseng LH; Cheng ML; Liau JY; Jeng YM
Mod Pathol; 2015 Feb; 28(2):268-78. PubMed ID: 25081749
[TBL] [Abstract][Full Text] [Related]
12. T-complex-associated-testis-expressed 3 (TCTE3) is a novel marker for pancreatobiliary carcinomas.
Zhao CL; Hui Y; Wang LJ; Lombardo K; Yang D; Mangray S; Yakirevich E; Amin A; Huang CK; Lu S
Hum Pathol; 2017 Dec; 70():62-69. PubMed ID: 29079176
[TBL] [Abstract][Full Text] [Related]
13. Annexin A10 is involved in the induction of pancreatic duodenal homeobox‑1 in gastric cancer tissue, cells and organoids.
Ishikawa A; Sakamoto N; Honma R; Taniyama D; Fukada K; Hattori T; Sentani K; Oue N; Yanagihara K; Tanabe K; Ohdan H; Yasui W
Oncol Rep; 2020 Feb; 43(2):581-590. PubMed ID: 31789399
[TBL] [Abstract][Full Text] [Related]
14. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
Bishop JA; Sharma R; Illei PB
Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
[TBL] [Abstract][Full Text] [Related]
15. High Annexin A10 expression is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Yamaguchi A; Kuwai T; Sudo T; Hadano N; Tashiro H; Taniyama K; Yasuif W
Histol Histopathol; 2022 Mar; 37(3):243-250. PubMed ID: 34821375
[TBL] [Abstract][Full Text] [Related]
16. Annexin A10 Expression Is Associated With Poor Prognosis in Small Bowel Adenocarcinoma.
Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Kuwai T; Shimizu Y; Sudo T; Tashiro H; Taniyama K; Yasui W
Anticancer Res; 2021 Mar; 41(3):1349-1355. PubMed ID: 33788726
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical Markers Distinguishing Cholangiocellular Carcinoma (CCC) from Pancreatic Ductal Adenocarcinoma (PDAC) Discovered by Proteomic Analysis of Microdissected Cells.
Padden J; Ahrens M; Kälsch J; Bertram S; Megger DA; Bracht T; Eisenacher M; Kocabayoglu P; Meyer HE; Sipos B; Baba HA; Sitek B
Mol Cell Proteomics; 2016 Mar; 15(3):1072-82. PubMed ID: 26644413
[TBL] [Abstract][Full Text] [Related]
18. Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma: a comparative study of immunohistochemical markers and panels.
Kälsch J; Padden J; Bertram S; Pott LL; Reis H; Westerwick D; Schaefer CM; Sowa JP; Möllmann D; Fingas C; Dechȇne A; Sitek B; Eisenacher M; Canbay A; Ahrens M; Baba HA
Virchows Arch; 2017 May; 470(5):537-543. PubMed ID: 28357490
[TBL] [Abstract][Full Text] [Related]
19. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary.
Cao D; Ji H; Ronnett BM
Int J Gynecol Pathol; 2005 Jan; 24(1):67-72. PubMed ID: 15626919
[TBL] [Abstract][Full Text] [Related]
20. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
